Why the study?
The study was undertaken to evaluate serum Gamma Glutamyl Transferase levels in patients with acute coronary syndrome.
Are serum Gamma-Glutamyl Transferase (GGT) levels elevated in patients with acute coronary syndrome compared to healthy controls?
Are serum Gamma-Glutamyl Transferase (GGT) levels elevated in patients with acute coronary syndrome compared to healthy controls?
Higher levels of GGT may serve as a biomarker to predict the occurrence of acute coronary syndrome in patients with risk factors.
Elevated GGT associated with ACS; hypothesis-generating, requiring prospective validation before any clinical role.
Aim: The present study was undertaken with the aim to evaluate serum Gamma Glutamyl Transferase (GGT) levels in patients of acute coronary syndrome. Methodology: This cross-sectional study was conducted on 50 cases with acute coronary syndrome (Group A) and 50 healthy control subjects (Group B) meeting inclusion and exclusion criteria. Results: There is signicant rise in serum GGT levels in patients presenting with ACS in Group A as compared to Group B. Conclusion: Higher levels of GGT in ACS patients with risk factors such as hypertension, dyslipidemia and smoking may serve as biomarker to predict the occurrence of ACS.
No takes yet. Share an insight, caveat, or question.
Dhanju et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: